2GZY | pdb_00002gzy

solution structures of the reduced form of thioredoxin from Bacillus subtilis

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_13C-separated_NOESY	1mM thioredoxin U-15N, 13C; 20mM Tris-HCl buffer; 20mM DTT	90% H2O/10% D2O	20mM Tris-HCl	6.8	ambient	298
2	3D_15N-separated_NOESY	1mM thioredoxin U-15N, 13C; 20mM Tris-HCl buffer; 20mM DTT	90% H2O/10% D2O	20mM Tris-HCl	6.8	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations, structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations, lowest energy)

Additional NMR Experimental Information
Details	The structure was determined using triple-resonance NMR spectroscopy.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Amber	7.0	Case, D.A. et al.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.